期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor
1
作者 Gui-Ming Deng hai-bin song +3 位作者 Zhong-Ze Du Ying-Wei Xue Hong-Jiang song Yuan-Zhou Li 《World Journal of Gastroenterology》 SCIE CAS 2024年第8期863-880,共18页
BACKGROUND The development and progression of gastric cancer(GC)are closely linked to the nutritional status of patients.Although immunotherapy has been demonstrated to be clinically effective,the relationships of sar... BACKGROUND The development and progression of gastric cancer(GC)are closely linked to the nutritional status of patients.Although immunotherapy has been demonstrated to be clinically effective,the relationships of sarcopenia and myosteatosis with the use of immune checkpoint inhibitors(ICIs)in patients with gastric cancer remain to be characterized.METHODS We performed a retrospective study of patients who were undergoing immuno-therapy for GC.For the evaluation of sarcopenia,the optimal cut-off value for the skeletal muscle index was established using receiver operating characteristic analysis of data obtained from pre-treatment computed tomography images at the L3 vertebral level.Myosteatosis was defined using the mean skeletal muscle density(SMD),with a threshold value of<41 Hounsfield units(HU)for patients with a body mass index(BMI)<25 kg/m^(2)and<33 HU for those with a BMI≥25 kg/m^(2).The log-rank test was used to compare progression-free survival(PFS)and overall survival(OS),and a Cox proportional hazard model was used to identify prognostic factors.Nomograms were developed to predict the PFS and OS of patients on the basis of the results of multivariate analyses.RESULTS We studied 115 patients who were undergoing ICI therapy for GC,of whom 27.4%had sarcopenia and 29.8%had myosteatosis.Patients with sarcopenia or myosteatosis had significantly shorter PFS and OS than those without these conditions.Furthermore,both sarcopenia and myosteatosis were found to be independent predictors of PFS and OS in patients with GC administering an ICI.The prediction models created for PFS and OS were associated with C-indexes of 0.758 and 0.781,respectively.CONCLUSION The presence of sarcopenia or myosteatosis is a reliable predictor of the clinical outcomes of patients with GC who are undergoing treatment with an ICI. 展开更多
关键词 Gastric cancer SARCOPENIA Myosteatosis Immune checkpoint inhibitor Prognostic factor Overall survival Progression-free survival
下载PDF
贝伐株单抗与阿帕替尼分别联合替莫唑胺治疗复发性高级别脑胶质瘤的近期及远期疗效分析 被引量:1
2
作者 全黎莉 宋海斌 宋丽良 《中国现代医学杂志》 CAS 北大核心 2022年第23期11-15,共5页
目的探究贝伐株单抗与阿帕替尼分别联合替莫唑胺(TMZ)治疗复发性高级别脑胶质瘤的近期及远期疗效。方法选取2018年3月—2020年3月武汉市第一医院107例复发性高级别脑胶质瘤患者作为研究对象,按照随机数字表法分为贝伐株单抗组(53例)和... 目的探究贝伐株单抗与阿帕替尼分别联合替莫唑胺(TMZ)治疗复发性高级别脑胶质瘤的近期及远期疗效。方法选取2018年3月—2020年3月武汉市第一医院107例复发性高级别脑胶质瘤患者作为研究对象,按照随机数字表法分为贝伐株单抗组(53例)和阿帕替尼组(54例)。贝伐珠单抗组予以贝伐珠单抗联合TMZ治疗;阿帕替尼组予以阿帕替尼联合TMZ治疗。评估两组治疗3个周期后的临床疗效,比较两组血清VEGF、EGFR水平,分析给药期间两组的药物毒性反应,并随访记录两组总生存期(OS)和2年生存率。结果阿帕替尼组治疗后客观缓解率和疾病控制率高于贝伐珠单抗组(P<0.05);贝伐珠单抗组治疗前后血清VEGF和EGFR的差值高于阿帕替尼组(P<0.05);贝伐珠单抗组治疗后血小板降低率高于阿帕替尼组(P<0.05);贝伐珠单抗组治疗后高血压发生率低于阿帕替尼组(P<0.05);截止随访时间,贝伐珠单抗组OS为13.5个月,2年生存率22.64%,阿帕替尼组OS为17个月,2年生存率44.44%,Kaplan-Meier生存曲线显示,阿帕替尼组生存率高于贝伐珠单抗组(P<0.05)。结论相对于贝伐珠单抗联合TMZ治疗方案,阿帕替尼联合TMZ治疗复发性高级别脑胶质瘤疗效更为优越,且可延长患者生存期。 展开更多
关键词 脑胶质瘤 复发性 高级别 贝伐株单抗 阿帕替尼 替莫唑胺 疗效 生存分析
下载PDF
Experimental investigation of electrode cycle performance and electrochemical kinetic performance under stress loading 被引量:1
3
作者 刘子涵 亢一澜 +2 位作者 宋海滨 张茜 谢海妹 《Chinese Physics B》 SCIE EI CAS CSCD 2021年第1期380-390,共11页
Lithium-ion batteries suffer from mechano–electrochemical coupling problems that directly determine the battery life. In this paper, we investigate the electrode electrochemical performance under stress conditions, w... Lithium-ion batteries suffer from mechano–electrochemical coupling problems that directly determine the battery life. In this paper, we investigate the electrode electrochemical performance under stress conditions, where seven tensile/compressive stresses are designed and loaded on electrodes, thereby decoupling mechanics and electrochemistry through incremental stress loads. Four types of multi-group electrochemical tests under tensile/compressive stress loading and normal package loading are performed to quantitatively characterize the effects of tensile stress and compressive stress on cycle performance and the kinetic performance of a silicon composite electrode. Experiments show that a tensile stress improves the electrochemical performance of a silicon composite electrode, exhibiting increased specific capacity and capacity retention rate, reduced energy dissipation rate and impedances, enhanced reactivity, accelerated ion/electron migration and diffusion, and reduced polarization. Contrarily, a compressive stress has the opposite effect, inhibiting the electrochemical performance. The stress effect is nonlinear, and a more obvious suppression via compressive stress is observed than an enhancement via tensile stress. For example, a tensile stress of 675 k Pa increases diffusion coefficient by 32.5%, while a compressive stress reduces it by 35%. Based on the experimental results, the stress regulation mechanism is analyzed. Tensile stress loads increase the pores of the electrode material microstructure, providing more deformation spaces and ion/electron transport channels. This relieves contact compressive stress, strengthens diffusion/reaction, and reduces the degree of damage and energy dissipation. Thus, the essence of stress enhancement is that it improves and optimizes diffusion, reaction and stress in the microstructure of electrode material as well as their interactions via physical morphology. 展开更多
关键词 prestress loading silicon composite electrode tensile stress enhancement compressive stress suppression
原文传递
Synthesis,crystal structure and 3D-QSAR studies of antifungal (bis-) 1,2,4-triazole Mannich bases containing furyl and substituted piperazine moieties 被引量:4
4
作者 Yan Zhang Yi-Zhou Zhan +6 位作者 Yi Ma Xue-Wen Hua Wei Wei Xiao Zhang hai-bin song Zheng-Ming Li Bao-Lei Wang 《Chinese Chemical Letters》 SCIE CAS CSCD 2018年第3期441-446,共6页
A series of novel title compounds 6 a-6 r and 7 a-7 c have been synthesized by Mannich reaction of the new triazole Schiff base intermidiates, substituted piperazine and formaldehyde under mild conditions in excellent... A series of novel title compounds 6 a-6 r and 7 a-7 c have been synthesized by Mannich reaction of the new triazole Schiff base intermidiates, substituted piperazine and formaldehyde under mild conditions in excellent yields. The crystal structure of compound 6 i was determined to show a chair conformation of the piperazine ring and an(E)-configuration of the C=N double bond. The bioassay results indicated that most of the newly synthesized compounds exhibited excellent in vitro inhibitory activities and broader spectrum against several plant fungi, and were more effective than the control Triadimefon. Several compounds also displayed favourable in vivo antifungal activities. The relationships between the compound structures and various biological activities were discussed. Furthermore, the CoMFA calculation based on the antifungal activity data of compounds 6 against R. cerealis was carried out to establish a 3 D-QSAR model, which revealed that steric and electrostatic fields were two most important factors for contributing the bioactivity of the compounds. The present work will provide significant information for guiding optimization of such new structures to develop novel agrochemicals with higher antifungal activities. 展开更多
关键词 3D-QSAR 水晶结构 抗真菌 合成 学习 Schiff 生物活动 复合结构
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部